Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

1.4 / 5 stars · 24/87 Roast Me

Elanco Animal Health Incorporated Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Elanco Animal Health Incorporated (ELAN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$17.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets

us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24

  • Elanco Animal Health Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-03-31 was $2.00M.
  • Elanco Animal Health Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$17.00M.
  • Elanco Animal Health Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$77.00M, a 182.80% decline from fiscal 2023.
  • Elanco Animal Health Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $93.00M, a 16.25% increase from fiscal 2022.
  • Elanco Animal Health Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $80.00M, a 5.26% increase from fiscal 2021.
Period endValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 monthValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month
2025-12-31-$17.00M
10-K · filed 2026-02-24
2024-12-31-$77.00M
10-K · filed 2026-02-24
2023-12-31$93.00M
10-K · filed 2026-02-24
2022-12-31$80.00M
10-K · filed 2025-02-25
2021-12-31$76.00M
10-K · filed 2024-02-26
2021-03-31$2.00M
10-Q · filed 2022-05-09
2020-12-31$72.00M
10-K · filed 2023-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05